EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute-Phase Dengue Antibody Profiles in Pediatric Patients: Influence on Viremia and Disease Manifestations

Florencia A Bonnin iD, Agostina Bruno, María Manuela Bono, Carolina A Lucero, Ludmila Niño, Mariela Del Giudice, Diego E Álvarez iD, Eduardo L López, Cybele C García iD, Marcelo O Quipildor, Laura B Talarico

Viruses · 03.07.2026 · 18 (7) · 741

DOI: 10.3390/v18070741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 03.07.2026. Verfasst von Florencia A Bonnin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigaciones Infectológicas y Biología Molecular (LIIBM), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Hos…. Hauptthemen laut MEDLINE: Viremia, Antibodies, Viral, Dengue, Dengue Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, National Scientific and Technical Research Council, Fundación Argentina de Infectología Pediátrica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary dengue infections are often linked to more severe clinical outcomes, yet pre-existing antibodies may exert either protective or pathogenic effects. To evaluate the role of acute-phase dengue antibodies in pediatric dengue, we analyzed clinical and laboratory features, viremia, and antibody profiles in children infected with DENV-1. We conducted a retrospective study of patients under 18 years diagnosed with DENV-1 in Salta, Argentina. Viremia was quantified by real-time RT-PCR; acute-phase IgG antibodies (within 7 days from symptom onset) against DENV, DENV-1, and DENV-NS1 were measured by immunoassays, and neutralizing antibodies by plaque reduction neutralization tests. Among 151 patients (median age 12 years), 62% presented dengue with warning signs and one case progressed to severe dengue. Viremia was higher in probable primary infections than in probable secondary infections and did not correlate with disease severity. Probable secondary infections were characterized by acute-phase antibody profiles that did not associate with DENV viremia. Age-stratified analyses revealed that adolescents exhibited higher viremia levels than younger children in probable primary infections, while viremia levels were comparable across age groups in probable secondary infections. Furthermore, children younger than 10 years displayed acute-phase antibody levels similar to those of adolescents. In adolescents with probable secondary infections, anti-DENV and anti-DENV-1 IgG were inversely correlated with platelet counts, whereas neutralizing and anti-DENV-NS1 antibodies showed no association. Collectively, these findings indicate that probable secondary DENV infections in our pediatric cohort were characterized by acute-phase antibodies that were not associated with viremia control, and that in adolescents, anti-DENV and anti-DENV-1 IgG antibodies likely associated with platelet depletion. These results highlight important implications for vaccine design, underscoring the need for vaccines that elicit strong neutralizing responses while minimizing cross-reactivity and the risk of antibody dependent enhancement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ViremiaAntibodies, ViralDengueDengue VirusHumansChildAdolescentMaleFemaleRetrospective StudiesAntibodies, NeutralizingImmunoglobulin GChild, PreschoolArgentinaCoinfection

Stichwörter der Autor:innen

clinical diseasedengue virusimmune statusneutralizing antibodypediatricviremia

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin G

Autor:innen und Institutionen

  • Laboratorio de Investigaciones Infectológicas y Biología Molecular (LIIBM), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Hospital de Niños Dr. Ricardo Gutiérrez, Ciudad Autónoma de Buenos Aires…
  • Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Ciudad Autónoma de Buenos Aires 1428, Argentina.
  • Hospital San Vicente de Paul, San Ramón de la Nueva Orán 4530, Salta, Argentina.
  • Instituto de Investigaciones Biotecnológicas (IIBIO), Universidad Nacional de San Martín (UNSAM)-CONICET, San Martín 1650, Buenos Aires, Argentina.
  • Departamento de Medicina, Programa de Enfermedades Infecciosas, Hospital de Niños Ricardo Gutiérrez, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires 1425, Argentina.
  • Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), UBA-CONICET, Ciudad Autónoma de Buenos Aires 1428, Argentina.

ORCID-Profile: Florencia A Bonnin, Diego E Álvarez, Cybele C García

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • National Scientific and Technical Research Council
  • Fundación Argentina de Infectología Pediátrica
  • Consejo Nacional de Investigaciones Científicas y Técnicas

Zitieren

APA

Bonnin, F. A., Bruno, A., Bono, M. M., Lucero, C. A., Niño, L., Del Giudice, M., Álvarez, D. E., López, E. L., García, C. C., Quipildor, M. O., & Talarico, L. B. (2026). Acute-Phase Dengue Antibody Profiles in Pediatric Patients: Influence on Viremia and Disease Manifestations. Viruses, 18(7), 741. https://doi.org/10.3390/v18070741

Vancouver

Bonnin FA, Bruno A, Bono MM, Lucero CA, Niño L, Del Giudice M, et al. Acute-Phase Dengue Antibody Profiles in Pediatric Patients: Influence on Viremia and Disease Manifestations. Viruses. 2026;18(7):741. doi:10.3390/v18070741

BibTeX
@article{Bonnin2026,
  author = {Bonnin, Florencia A and Bruno, Agostina and Bono, María Manuela and Lucero, Carolina A and Niño, Ludmila and Del Giudice, Mariela and Álvarez, Diego E and López, Eduardo L and García, Cybele C and Quipildor, Marcelo O and Talarico, Laura B},
  title = {Acute-Phase Dengue Antibody Profiles in Pediatric Patients: Influence on Viremia and Disease Manifestations},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {741},
  doi = {10.3390/v18070741}
}
Kostenlos starten →